Clinical Trial: Clinical Evaluation of the Photoallergy Potential of Atralin Gel

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Clinical Evaluation of the Photoallergy Potential of Atralin Gel (Tretinoin Gel 0.05%)

Brief Summary: To assess the potential of tretinoin gel 0.05% and its vehicle to produce photoallergic reactions, measured as skin reactions following induction and challenge.

Detailed Summary:
Sponsor: Coria Laboratories, Ltd.

Current Primary Outcome: UV Induced skin irritation [ Time Frame: 4 days ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Coria Laboratories, Ltd.

Dates:
Date Received: January 8, 2008
Date Started: January 2008
Date Completion:
Last Updated: May 5, 2008
Last Verified: February 2008